| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.2 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |